EUCAST News
Here you can find the latest news and updates from EUCAST.
Susceptibility testing of anaerobic bacteria
EUCAST has developed a disk diffusion method for AST of five important anaerobic species (Bacteroides spp, Prevotella spp., Fusobacterium necrophorum, Clostridium perfringens and Cutibacterium acnes). Methodology, QC criteria and...[more]
Disk diffusion methodology and QC of anaerobic bacteria
Three months ahead of releasing breakpoints and disk diffusion correlates EUCAST publishes the methodology, the QC criteria and a disk diffusion reading guide.[more]
Review: vanco, teico, tela, dalba and oritavancin
Vancomycin, teicoplanin, telavancin, dalbavancin and oritavancin reviewed.[more]
Review: Azithromycin, Telithromycin, Spiramycin, Tulathromycin
As part of the 2020-2021 general review and revision of MIC distributions and ECOFFs, these agents were now completed.[more]
Review of MIC distributions of several agents
MIC distributions of several agents (trimethoprim-sulfamethoxazole, trimethoprim, rifampicin, erythromycin, clarithromycin) were reviewed as part of the 2021 full review of the entire MIC distribution database.[more]
Brief information on EUCAST definitions of S, I and R to clinical colleagues.
An abbreviated information on the EUCAST 2019/20 changes to the definitions and use of S, I and R. Please distribute to clinical colleagues who are normally not up to date on susceptibility testing matters.[more]
EUCAST calibration and validation graphs updated
Calibration and validation graphs related to breakpoint table v 11.0 (2021) updated 1 July, 2021.New for 2021, apart from introducing revised and new breakpoints for relevant agents and species,are graphs for...[more]
